Novo Nordisk partners with Septerna on obesity drugs

breakingthenews.net/Article/Novo-Nordisk-partners-with-Septerna-on-obesity-drugs/64108675

Novo Nordisk announced on Wednesday the collaboration with the United States company Septerna on oral medicines for obesity, type 2 diabetes and other diseases.Per agreement, Septerna will receive $2....

This story appeared on breakingthenews.net, 2025-05-14 12:21:00.
The Entire Business World on a Single Page. Free to Use →